drugset / Trial / NCT02132832
Buspirone, Stress, and Attentional Bias to Marijuana Cues
Phase 2
Completed
45 enrolled
The University of Texas Health Science Center, Houston
National Institute on Drug Abuse (NIDA) · collab
RandomizedParallel-groupTriple-blindBasic science
Summary
This project has two primary goals. The first goal is to further scientific understanding about marijuana abuse by examining two recognized factors in marijuana use and relapse: (1) stress/anxiety and (2) atypical reactivity to marijuana-related stimuli (e.g., attentional bias). The second goal is to attenuate the influence of stress/anxiety and attentional bias to marijuana stimuli via administration of buspirone. Buspirone is uniquely suited to this project because it has effects on neurotransmitter systems known to modulate both stress/anxiety and attentional bias.
Timeline
- Start
- 2013-06
- Primary completion
- 2016-03
- Completion
- 2016-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buspirone | Small molecule | 40 mg | Oral |